In this study, we examined the Ca 2+ -permeable Piezo1 channel, a newly identified mechanosensing ion channel, in human dental pulp-derived mesenchymal stem cells (MSCs) and hypothesized that activation of the Piezo1 channel regulates MSC migration via inducing ATP release and activation of the P2 receptor purinergic signaling. The Piezo1 mRNA and protein were readily detected in hDP-MSCs from multiple donors and, consistently, brief exposure to Yoda1, the Piezo1 channel-specific activator, elevated intracellular Ca 2+ concentration. Yoda1-induced Ca 2+ response was inhibited by ruthenium red or GsMTx4, two Piezo1 channel inhibitors, and also by Piezo1-specific siRNA. Brief exposure to Yoda1 also induced ATP release. Persistent exposure to Yoda1 stimulated MSC migration, which was suppressed by Piezo1-specific siRNA, and also prevented by apyrase, an ATP scavenger, or PPADS, a P2 generic antagonist. Furthermore, stimulation of MSC migration induced by Yoda1 as well as ATP was suppressed by PF431396, a PYK2 kinase inhibitor, or U0126, an inhibitor of the mitogen-activated protein kinase MEK/ERK signaling pathway. Collectively, these results suggest that activation of the Piezo1 channel stimulates MSC migration via inducing ATP release and subsequent activation of the P2 receptor purinergic signaling and downstream PYK2 and MEK/ERK signaling pathways, thus revealing novel insights into the molecular and signaling mechanisms regulating MSC migration. Such findings provide useful information for evolving a full understanding of MSC migration and homing and developing strategies to improve MSC-based translational applications. K E Y W O R D S ATP release, MEK/ERK, P2 receptor, Piezo1 channel, PYK2
| INTRODUCTION
Mesenchymal stem cells (MSCs), which have been isolated from bone marrow, umbilical cord, dental pulp, and a diversity of other tissues, have the ability of differentiating into tissue-specific lineages. [1] [2] [3] An increasing number of studies have demonstrated promising applications of MSCs in regenerative medicine and tissue engineering to repair and regenerate damaged or lost tissues due to diseases and traumatic injuries [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] and, nonetheless, translational uses of MSCs remain inefficacious, in part due to their limited capability of migrating and homing. 3, [22] [23] [24] [25] [26] Thus, gaining insights into the mechanisms regulating MSC migration can provide useful information for developing novel strategies to prepare MSCs for clinical applications and improve the efficacy of MSC-based therapies as well as evolving a better understanding of the contentious MSC biology. 27, 28 A multiplicity of extracellular signaling molecules and cell surface receptors for them and coupled intrinsic signaling mechanisms have been shown to regulate cell migration. [29] [30] [31] [32] ATP represents one such signaling molecule that selectively activates the P2 purinergic receptor family, which is composed of ligand-gated ion channel P2X receptors and G-proteincoupled P2Y receptors. 32, 33 ATP-induced purinergic signaling has been well documented in MSCs from different species and tissues 34 and, furthermore, has been demonstrated to play an important role in regulating MSC proliferation 35, 36 and differentiation 37, 38 as well as migration and homing. 39, 40 Increasing evidence indicates that various physical and chemical stimuli can stimulate ATP release from MSCs. 35, 38 MSCs are mechanosensitive, 41, 42 and mechanical forces can induce ATP release, but the mechanisms for mechanical induction of ATP release from MSCs remain poorly understood. 32 The Ca 2+ -permeable Piezo1 channel is a newly discovered mechanosensing mechanism in many types of cells. [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] Furthermore, recent studies have reported that mechanical or chemical activation of the Piezo1 channel induces ATP release from endothelial cells, 48 urothelial cells, 54 and red blood cells. 55 There is also compelling evidence to support a critical role for the Piezo1 channel in regulating cell migration in endothelial cells, 56 breast cancer cells, 57 gastric cancer cells, 50, 58 and small lung cancer cells. 59 Recent studies have also shown the expression of the Piezo1 channel in human bone marrow-derived MSCs (BM-MSCs) 60 and rat dental pulpderived stem cells (DP-MSCs). 61 Therefore, it is attractive to hypothesize that the Piezo1 channel regulates MSC migration via inducing ATP release and subsequent activation of the P2 receptor purinergic signaling. 32, 40 Recent studies have reported that the mitogen-activated protein kinase/extracellular signal-regulated kinase (MEK/ERK) or ERK is critically engaged as a downstream signaling pathway in mediating acetylcholine-induced rat BM-MSC migration 62 and interleukin-1βinduced human umbilical cord-derived MSC (UC-MSC) migration. 63 It has been proposed that the Piezo1 channel mediates ultrasound-induced activation of the MEK/ERK signaling pathway in rat DP-MSCs. 61 The proline-rich tyrosine kinase 2 (PYK2) is well-known as a signaling molecule downstream of intracellular Ca 2+ and plays a critical role in mediating Ca 2+ -dependent induction of the MEK/ERK pathway in monocyte, microglial, and neuronal cells. [64] [65] [66] [67] [68] [69] [70] There is evidence for involvement of PYK2 in cancer cell migration, 70 but it is unclear whether PYK2 plays a role in the regulation of MSC migration. Therefore, in this study, we examined the expression of the Piezo1 channel in human dental pulp-derived MSCs (hDP-MSCs) and its role in the regulation of cell migration. Particularly, we investigated the hypothesis of activation of the Piezo1 channel as a mechanism regulating hDP-MSC migration via inducing ATP release and subsequent activation of the P2 receptor purinergic signaling. We also explored the role of PYK2 and MEK/ERK as the downstream signaling pathways in mediating hDP-MSC migration. Our results show functional expression of the Piezo1 channel in hDP-MSCs and its important role in stimulating cell migration, and provide further evidence to support that activation of the Piezo1 channel stimulates cell migration via inducing ATP release and subsequent activation of the P2 receptor purinergic signaling and downstream PYK2 and MEK/ERK signaling pathways. These novel findings provide a better understanding of the molecular and signaling mechanisms regulating MSC migration and useful information for the development of strategies to improve applications of MSCs in regenerative medicine and tissue engineering.
| MATERIALS AND METHODS

| Chemicals and media
All chemicals or reagents were obtained from Sigma-Aldrich, unless specified otherwise. Yoda1, PF431396, GsMTx4, and PPADS were from Tocris. U0126 and ionomycin were from Cayman Chemical. Ruthenium red (RR) was from Merck. Ca 2+ /Mg 2+ -free phosphate-buffered saline (PBS), Dulbecco's modified Eagle's medium (DMEM), GlutaMAX-I, OPTI-MEM, fetal bovine serum (FBS), penicillin-streptomycin, trypsin-EDTA, Fura-2/acetoxymethyl (Fura-2/AM), and pluronic acid F-127 were from Invitrogen.
| Cell culture
Human DP-MSCs were isolated from the molar teeth from two female donors of 9 and 32 years old and two male donors of 22 and 20 years old (9F, 32F, 22M, and 20M in abbreviation) and characterized for the expression of positive and negative cell surface MSC
Significance statement
Mesenchymal stem cells (MSCs) release ATP as an extracellular signaling molecule in response to mechanical and diverse other stimuli, but the underlying mechanisms remain largely elusive.
This study shows the expression of the Ca 2+ -permeable Piezo1 channel, a newly discovered mechanosensing mechanism, in human dental pulp-derived MSCs and its important role in the regulation of MSC migration. It further demonstrates that activation of the Piezo1 channel stimulates MSC migration via inducing ATP release and subsequent activation of P2 receptor purinergic signaling. This study thus provides novel insights into the mechanisms regulating MSC migration. Such information is useful for gaining a better understanding of MSC migration and designing strategies to improve applications of MSCs in tissue engineering and regenerative medicine. markers and in vitro differentiation potentials as described in our previous study. 40 Cells were maintained in DMEM supplemented with GlutaMAX-I, 10% FBS and 100 units/mL penicillin and 100 μg/mL streptomycin at 37 C and 5% CO 2 in a tissue culture incubator. Cells, when reaching 80-90% confluency, were passaged and, when cells were settled down during incubation for 24 hours, the growth medium was replaced with fresh growth medium. Cells of 4-6 passages were used in this study.
| RT-qPCR analysis
Cells were plated at 80 000 per well in six-well plates. Cells were collected when reaching 80-90% confluency, and total RNA was extracted using a RNAqueous-Micro kit and treated with a TURBO DNA-free kit . The PCR products were also analyzed by electrophoresis on 2% agarose gels, and gel images were captured with a G:BOX gel imaging system (Syngene).
| Immunocytochemistry
Cells were seeded on sterile 13-mm circular glass coverslips placed in 24-well plates at 20 000 cells per well and incubated for 48 hours. Cells were washed twice with PBS and fixed with 4% paraformaldehyde for 20 minutes. After washed with PBS three times, cells were permeabilized by incubation in PBS containing 0.3% Triton X-100 for 5 minutes.
Cells were washed three times with PBS and incubated in PBS containing 10% goat serum for 1 hour at room temperature. Cells were incubated with the primary rabbit anti-Piezo1 antibody (Proteintech) at a dilution of 1:100 overnight at 4 C. After washed with PBS three times, cells were incubated with the secondary fluorescein isothiocyanateconjugated goat anti-rabbit IgG antibody at 1:500 at room temperature for 1 hour in dark. After washed with PBS and rinsed with water, cells were mounted on a microscope slide with antifade mounting medium containing 4 0 ,6-diamidino-2-phenylindole (DAPI) (Invitrogen).
Fluorescent images were captured using a LMS880 confocal microscope and the ZEN software (Zeiss) or an EVOS Cell Imaging System (Thermo Fisher Scientific, Waltham, MA, USA).
| Measurements of intracellular Ca 2+ concentration
The intracellular Ca 2+ concentration ([Ca 2+ ] i ) was monitored using Fura-2/AM and a Flex-Station III microplate reader (Molecular Devices) as described in our previous study. 40 72 
| Cell migration assay
Cell migration was determined using the wound healing assay as described in our previous study, 40 was presented by expressing the wound healing as percentage of that under control condition at the same time points (eg, Figure 3F ).
| Measurement of ATP release
ATP release was determined using a StayBrite Highly Stable ATP Bioluminescence Assay kit (BioVision) to measure the ATP concentration in the culture medium according to the manufacturer's instructions.
Cells were plated at 50 000-60 000 cells/well in 200 μL of standard culture medium in a 96-well plate and incubated overnight. Next day, cells were subjected to starvation by replacing the culture medium with fresh media without FBS and incubating for 2 hours. Cells were treated with 100 μM suramin for 30 minutes at 37 C in order to prevent ATP hydrolysis, as described in a previous study. 38 After cells were exposed to 1 μM Yoda1 for 30 minutes at 37 C, the culture medium were collected, placed in 1.5-mL Eppendorf tubes on ice, and centrifuged at 11 000g for 5 minutes at 4 C. The supernatants were transferred to a 96-well plate with 10 μL per well in triplicate for each condition. The luminescence intensity was measured using a Flex-Station III microplate reader. The ATP concentration was derived using a standard curve constructed using 10, 30, 100, 1000, and 10 000 nM ATP.
| Data presentation and statistical analysis
All data are presented as mean ± SEM, where appropriate. Statistical analysis was performed using Origin; Student's t test was used for comparison between two groups, and one-way ANOVA followed by
Fisher's test for comparison of multiple groups, with P < .05 being statistically significant. Figure 1A and Supplementary Figure S1) . Consistently, as observed in cells from all the donors, there were positive and also variable immunoreactivities in cells labeled with the anti-Piezo1 antibody but not in cells labeled only with the secondary antibody ( Figure 1B) . We next examined the functional expression of the Piezo1 channel in hDP-MSCs by monitoring intracellular Ca 2+ responses to Yoda1, the Piezo1 channel-specific activator. 73 In extracellular Ca 2+ -containing solution, brief exposure to Figure S4 ). Taken together, these results provide pharmacological and genetic evidence that consistently supports the expression of the Piezo1 channel in hDP-MSCs.
| Activation of the Piezo1 channel stimulates hDP-MSC migration
To test whether the Piezo1 channel plays a role in regulating hDP-MSC migration, as recently reported in endothelial cell 56 B, Summary of mean wound healing from three independent experiments for cells from 9F under control condition (CTL) and cells exposed to 0.3 μM Yoda alone (Yoda1) or together with 0.3 or 1 U/mL apyrase (Apy + Yoda1). C, Summary of mean wound healing in three independent experiments for cells from 9F under CTL and cells exposed to 0.3 μM Yoda1 alone (Yoda1) or together with 30 μM PPADS (PPAD+Yoda1). *P < .05 compared to control condition at the same time points and # P < .05 compared to cells exposed to Yoda1 alone F I G U R E 6 The PYK2 and MEK/ERK signaling pathways are critical for ATP-induced stimulation of hDP-MSC migration. A, Representative wound healing in cells from 9F under control (CTL) or cells exposed to 30 μM ATP, indicated by the reduction in the wound area expressed as percentage of the wound area at 0 hour. B, Summary of mean wound healing as percentage of that under CTL at the same time points in parallel experiments, from 10 independent experiments using cells from 9F and 22M. C,D, Summary of mean wound healing in three independent experiments for cells from 9F under CTL and cells exposed to 30 μM ATP alone (ATP) or together with 10 nM of PF431396 (PF + ATP, C) or 1 μM U0126 (U0126 + ATP, D). *P < .05 and **P < .001 compared to control condition at the same time points, and # P < .05 and ## P < .001 compared to cells exposed to ATP alone (C and D) stimulation of cell migration was sustained in cells transfected with control siRNA but lost in cells transfected with Piezo1-specific siRNA, which was consistently observed in cells from two donors tested ( Figure 3G ).
These results support that activation of the Piezo1 channel stimulates hDP-MSC migration. Figure 5B ). Importantly, treatment with apyrase alone was without significant effect on cell migration (Supplementary Figure S5A) .
These results indicate that ATP release mediates Yoda1-induced stimulation of hDP-MSC migration. Our previous study showed that treatment with 30 μM PPADS, a generic P2 receptor antagonist, prior to and during exposure to ATP, effectively prevented ATP-induced stimulation of hDP-MSC migration. 40 Treatment with 30 μM PPADS also resulted in strong inhibition of Yoda1-induced stimulation of cell migration ( Figure 5C ).
Again, treatment with PPADS alone had no effect on cell migration (Supplementary Figure S5B) . Taken together, these results provide consistent evidence to show that activation of the Piezo1 channel stimulates hDP-MSC migration via inducing ATP release and P2 receptor activation.
If the above-described notion is correct, we anticipate that activation of the PKY2 and MEK/ERK signaling pathways are also critical in ATPinduced stimulation of hDP-MSC migration. Exposure to 30 μM ATP stimulated cell migration in hDP-MSCs from two donors used ( Figure 6A,B) , as reported in our previous study. 40 Indeed, ATP-induced stimulation of cell migration was prevented by treatment with PF431396 or U0126
( Figure 6C,D) , as shown above for Yoda1 (Figure 4 ). These results have extended our previous finding 40 
| DISCUSSION
We in this study showed the expression of the Piezo1 channel in hDP-MSCs as a previously unrecognized mechanism regulating human MSC migration. We provide further evidence to suggest that activa- Our study provides independent lines of evidence to demonstrate the expression of the Piezo1 channel in hDP-MSCs. The Piezo1 mRNA and protein were detected in all the cell preparations from four donors, albeit with some noticeable variations among the different donors ( Figure 1A,B and Supplementary Figure S1 ). Consistently, brief exposure to Yoda1 induced Ca 2+ influx-dependent increases in the [Ca 2+ ] i in hDP-MSCs from all the donors ( Figure 1C-H) . Moreover, as shown in cells from multiple donors, Yoda1-induced Ca 2+ responses were inhibited by RR and GsMTx4, and also by siRNA-mediated knockdown of the Piezo1 expression ( Figure 2 and Supplementary Figures S2-S4) .
These results provide strong evidence to show the expression of the Piezo1 channel in hDP-MSCs. Our study, together with a recent study examining hBM-MSCs, 60 ( Figure 1E-H) , suggesting that the Piezo1 channel is located in the plasma membrane, as described in many other types of cells. 43, 44, 54 Recent studies have reported a role for the Piezo1 channel in regulating cell migration in endothelial cell 56 and cancer cells. 50, [57] [58] [59] In this study, we provide evidence to show that the Piezo1 channel plays a simi- In this study, we have gained further insights into Piezo1-dependent regulation of hDP-MSC migration. Recent studies support a critical role for the Piezo1 channel, upon mechanical or chemical activation, in inducing ATP release from urothelial cell, 54 red blood cell, 55 and endothelial cell. 48 Here, we showed that activation of the Piezo1 channel with Yoda1 induced substantial ATP release from hDP-MSCs ( Figure 5A ). Moreover, Yoda1 became ineffective in stimulating cell migration in the presence of apyrase, a potent ATP scavenger ( Figure 5B ), indicating that ATP release mediates Piezo1-dependent regulation of cell migration. These findings are nicely aligned with our previous study showing that application of ATP stimulates hDP-MSC migration under the same experimental conditions, 40 which we have confirmed in this study ( Figure 6A,B) . We further showed that Yoda1-induced Piezo1-dependent stimulation of hDP-MSC migration was strongly inhibited by PPADS ( Figure 5B ). Taken together, these results strongly support that activation of the Piezo1 channel stimulates hDP-MSC migration via inducing ATP release and subsequent activation of the P2 receptor purinergic signaling. Our previous study identified P2X7, P2Y1, and P2Y11 as the major P2 receptors that mediate ATP-induced increase in hDP-MSC migration. 40 It is anticipated that these P2 receptors are engaged in Piezo1-dependent stimulation of hDP-MSC migration but the supporting evidence is required.
In this study, we have also shed light on the downstream signaling pathways in Piezo1-dependent stimulation of hDP-MSC migration as well as ATP-induced P2 receptor-dependent stimulation of hDP-MSC migration reported in our previous study. 40 PYK2 is a well-recognized signaling mechanism transducing Ca 2+ -dependent induction of the MEK/ERK signaling pathway. 64, 66, 67, 69, 70 Our results from hDP-MSCs from three donors showed that Yoda1-induced cell migration was prevented by inhibiting PYK2 (Figure 4A -D) and MEK/ERK ( Figure 4E-H) . These results strongly suggest that the PYK2 and MEK/ERK signaling pathways are critically engaged in Piezo1-dependent stimulation of cell migration. Our finding is also consistent with a recent study proposing a role for the Piezo1 channel in rat DP-MSCs in mediating ultrasound-induced activation of the MEK/ERK signaling pathway. 61 
| CONCLUSION
In conclusion, we show that activation of the Piezo1 channel as a novel mechanism to stimulate in MSC migration via inducing ATP release and subsequent activation of the P2 receptor purinergic signaling and downstream PYK2 and MEK/ERK signaling pathways. Such novel insights into the molecular and signaling mechanisms in the regulation of MSC migration should be useful for a better understanding of the MSC biology and translational use of MSCs in regenerative medicine and tissue engineering.
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